-
Macroeconomic Analysis
NewChina PESTLE Insights – A Macroeconomic Outlook Report
Mining, manufacturing and utilities activities contributed 32.8% to the gross value added (GVA) in 2023, followed by wholesale, retail and hotels activities (11.1%), agricultural activities (7.7%). In nominal terms, the three sectors are expected to grow by 7.9%, 6.7% and 6.2%, respectively, in 2024. Eastern China accounts for most of the provincial GDP in 2023. Beijing, Shanghai, Jiangsu and Guangzhou are the major cities of Eastern China. Better sea connectivity has boosted manufacturing in these cities.
-
Government & Regulation
NewCanada Mining Fiscal Landscape – Regulations Governance and Sustainability
Canada Mining Fiscal Landscape Report Overview Canada is one of the largest mineral producers globally and produces more than 60 metals and minerals, including potash, uranium, platinum, indium, and aluminium, among others. Furthermore, Canada is one of the world's largest bauxite importers. Canada’s mining industry is governed by different departments and agencies under provincial governments. However, in cases such as mineral activities on federal lands and offshore areas, as well as the usage of uranium as a nuclear fuel, a...
-
Sector Analysis
Pakistan Renewable Energy Policy Handbook, 2024 Update
"Pakistan Renewable Energy Policy Handbook 2024” is among the latest country specific policy reports from GlobalData, the industry analysis specialist. The report offers comprehensive information on major policies governing the renewable energy market in the country and provides information on renewable policies/developments at a regional/municipal level. The report discusses renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of the renewable energy industry. The report also provides major technology specific...
-
Sector Analysis
Vietnam Renewable Energy Policy Handbook, 2024 Update
"Vietnam Renewable Energy Policy Handbook 2024” is among the latest country specific policy reports from GlobalData, the industry analysis specialist. The report offers comprehensive information on major policies governing the renewable energy market in the country and provides information on renewable policies/developments at a regional/municipal level. The report discusses renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of the renewable energy industry. The report also provides major technology specific...
-
Product Insights
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) – Drugs In Development, 2023
Global Markets Direct’s, ‘B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) - Drugs In Development, 2023’, provides an overview of the B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the...
-
Sector Analysis
Asia Pacific (APAC) Renewable Energy Policy Handbook, 2024 Update
Asia Pacific (APAC) Renewable Energy Policy Report Overview All Asia Pacific (APAC) countries covered in this report have set targets for renewable energy deployment and generation. A few countries have capacity targets, and a few have generation targets. In the APAC region, feed-in tariff (FiT) has been predominantly the most popular form of incentive utilized to promote renewable power installations. However, competitive bidding or auctions have also gained popularity in the APAC countries to promote renewable energy, especially solar PV,...
-
Product Insights
B-Cell Chronic Lymphocytic Leukemia – Drugs In Development, 2023
Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Drugs In Development, 2023’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for B-Cell Chronic Lymphocytic Leukemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Gastrointestinal Tumor – Drugs In Development, 2023
Global Markets Direct’s, ‘Gastrointestinal Tumor - Drugs In Development, 2023’, provides an overview of the Gastrointestinal Tumor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gastrointestinal Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Drugs In Development, 2023
Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Drugs In Development, 2023’, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...
-
Product Insights
B-Cell Leukemia – Drugs In Development, 2023
Global Markets Direct’s, ‘B-Cell Leukemia - Drugs In Development, 2023’, provides an overview of the B-Cell Leukemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for B-Cell Leukemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...